%0 Journal Article %T Pembrolizumab in metastatic mismatch repair deficient colorectal cancer: the beginning of a journey into the land of immunotherapies for all cancers %A Grothey, Axel %J Chinese Clinical Oncology %D 2022 %B 2022 %9 %! Pembrolizumab in metastatic mismatch repair deficient colorectal cancer: the beginning of a journey into the land of immunotherapies for all cancers %K %X %U https://cco.amegroups.org/article/view/103542 %V 11 %N 5 %P 37 %@ 2304-3873